Chao Yen Huang

Dr. Chao Yen Huang

orcid

Research Focus & Metrics

Representative Publications

View All Publications
29 April 2023 in Journal of Dental Sciences
Verified
Journal Article
Open access
CHChao Yen Huang
Chao Yen Huang
Min Yee NgMin Yee Ng
Min Yee Ng
TLTaichen Lin
Taichen Lin
YLYi-Wen Liao
Yi-Wen Liao
WHWei-Shiuan Huang
Wei-Shiuan Huang
CCChun-Jung Chen
Chun-Jung Chen
Diabetes mellitus (DM) and periodontal disease are both prevalent and chronic inflammatory disorders that have significant health impact. Many studies have pointed out that advanced glycation end-products (AGEs) in DM induces inflammaging, which is a pre-aging and hyperinflammatory condition, and it has been linked to a greater likelihood in developing periodontitis. Inflammaging in DM has been shown to be driven by AGEs-induced cell senescence, inflammatory cytokines, and oxidative stress, resulting in the degradation of periodontium. Quercetin has shown abilities to decrease inflammation and oxidative stress in a variety of tissues, however, the effect in diabetic periodontitis remains uncertain. Thus, the aim of this study was to investigate its impacts on inflammaging in diabetic periodontitis. We examined cell proliferation in human gingival fibroblasts (HGF), wound healing, IL-6 and IL-8 secretions, cellular senescence expression, and the formation of reactive oxygen species (ROS) in response to AGE stimulation with and without Quercetin intervention. Following that, we looked into NF-κβ activity to see if Quercetin mediate its effects via this pro-inflammatory signaling. Quercetin at 20 μM and below did not have any impact on HGFs’ cell proliferation rate. Quercetin intervention improved the AGEs-impaired wound healing, in addition to the attenuation of AGEs-induced ROS in a dose-dependent pattern. Moreover, Quercetin therapy dose-dependently inhibited AGEs-induced cell senescence activity along with its senescence associated secretion phenotype (SASP) secretions such as IL-6 and IL-8. Western blot analysis indicated that Quercetin was able to reverse the phosphorylation of p65 and Iκβ in AGEs-stimulated HGFs, demonstrating it can modulate NF-κβ pathway. Accumulation of AGEs can elicit inflammaging in HGFs, as seen by increased pro-inflammatory cytokines, cell senescence expression and oxidative stress. The results proposed that Quercetin is able to ameliorate inflammaging in diabetic periodontitis and improve wound healing via the suppression of NF-κβ pathway and hence, may be a promising approach for treatment of diabetes-associated periodontitis.

26 October 2023 in Journal of Dental Sciences
Verified
Journal Article
Open access
CHChao Yen Huang
Chao Yen Huang
SCSzu-Han Chen
Szu-Han Chen
TLTaichen Lin
Taichen Lin
YLYi-Wen Liao
Yi-Wen Liao
YCYu-Cheng Chang
Yu-Cheng Chang
CCChun-Jung Chen
Chun-Jung Chen
The accumulation of advanced glycation end products (AGEs) lead to a series of immune responses such as: increased oxidative stress and inflammation which contribute to the development of diabetic complications and periodontal disease. Resveratrol is a natural compound that has anti-oxidant and anti-inflammatory effects. Studies have found that diabetes-induced periodontitis is mainly caused by oxidative stress, aging and increased inflammation. In view of resveratrol has been proposed to have the ability in anti-oxidant and anti-inflammation in a variety of tissues. However, the role of resveratrol in diabetic periodontitis remains to be investigated. In this study, we aimed to investigate the role of resveratrol in preventing and treating diabetic periodontitis. First, cell proliferation was measured in AGEs-treated human gingival fibroblast with or without resveratrol. We examined the reactive oxygen species (ROS) generation, senescence-associated beta-galactosidase (SA-β-gal) and senescence marker p16 in human gingival fibroblasts (HGFs) stimulated with AGEs with or without the treatment of resveratrol. To determine whether resveratrol has the potential to regulate inflammaging which is mediated via the NF-κB signaling pathway and, the expression of p65 and p-IκB were also investigated. Furthermore, the concentration of interleukin (IL)-6 and IL-8 were also measured in AGEs-stimulated HGFs treated with or without resveratrol. ROS generation, cell senescence, and the secretion of IL-6 and IL-8 were significantly upregulated following the treatment of AGEs. However, the administration of resveratrol suppresses the generation of IL-6 and IL-8 and cell senescence via inhibiting NF-κB signaling pathway. Our results revealed that resveratrol inhibits inflammaging by downregulating NF-κB signaling pathway. According to our findings, AGEs increase senescence and the production of proinflammatory cytokines in the gingiva, while the administration of resveratrol impedes inflammaging via suppressing NF-κB signaling pathway.

1 May 2022 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
CHChao Yen Huang
Chao Yen Huang
PHPei-Ling Hsieh
Pei-Ling Hsieh
MNMin Yee Ng
Min Yee Ng
YLYi-Wen Liao
Yi-Wen Liao
Cheng-Chia YuCheng-Chia Yu
Cheng-Chia Yu
TLTaichen Lin
Taichen Lin
Periodontitis is a progressive inflammation condition and a primary cause of tooth loss in adults. As one of the abundant cell types in the periodontium, periodontal ligament fibroblasts (PDLFs) play an integral role in the maintenance and regeneration of periodontal tissue. Our previous work has shown that the application of Er:YAG laser increased the cell proliferation and migratory capacity of PDLFs via induction of galectin-7. In the present study, we aimed to evaluate if the forced expression of galectin-7 directly affected the cellular phenotypes of PDLFs. Our results showed that the cell proliferation, transwell migration, invasion, and wound healing capacities were all upregulated in PDLFs with the ectopic expression of galectin-7. These results suggest that therapeutic approaches to enhance the expression of galectin-7 in periodontium may accelerate tissue regeneration by recruiting more PDLFs to the injured site.

14 March 2025 in Journal of Dental Sciences
Verified
Journal Article
Open access
CHChao Yen Huang
Chao Yen Huang
PCPei-Yin Chen
Pei-Yin Chen
Min Yee NgMin Yee Ng
Min Yee Ng
YLYi-Wen Liao
Yi-Wen Liao
CYCheng-Chia Yu
Cheng-Chia Yu
SCSzu-Han Chen
Szu-Han Chen
The incidence of diabetes mellitus (DM) has gradually increased in recent years. DM and its complications impose a substantial burden on healthcare systems. Chronic hyperglycemia results in the accumulation of advanced glycation end products (AGEs), which in turn elevate oxidative stress and inflammation, thereby contributing to diabetic complications, including impaired wound healing. γ-Mangostin, a mangostin isolated from the pericarp of mangosteen fruit, has been reported to possess antioxidant and anti-inflammatory properties. Our study aimed to investigate the effects of γ-mangostin on AGEs-induced impairment of wound healing and inflammaging. Human gingival fibroblasts (HGFs) were isolated from gingival tissues obtained from patients undergoing crown lengthening surgery. HGFs were treated with AGEs for 24 h, followed by treatment with 0.5–2 μg/mL γ-mangostin for another 24 h. Cell proliferation, wound healing capacity, oxidative stress, cell senescence, pyroptosis, and pro-inflammatory cytokine expression were then assessed. Our study found that γ-mangostin at 0.5–2 μg/mL had no effect on HGFs proliferation rate. Furthermore, γ-mangostin restored AGE-induced wound healing impairment and decreased ROS generation. γ-Mangostin reduced AGEs-induced increases in senescence-related β-galactosidase (SA-β-gal) activity and senescence markers p16 and p21. Furthermore, γ-mangostin decreased the expression of pyroptosis-related markers, including as ASC, NLR family pyrin domain-containing 3 (NLRP3), pro-caspase-1, and cleaved gasdermin D (GSDMD). Finally, γ-mangostin inhibited the AGE-induced production of pro-inflammatory cytokines IL-6 and IL-8. Our findings suggest that AGEs impair wound healing and promote oxidative stress, cellular senescence, pyroptosis, and inflammation. γ-Mangostin treatment mitigated these effects, potentially by attenuating inflammation and pyroptosis, thereby improving wound healing.

10 September 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
WLWan-Chih Lin
Wan-Chih Lin
Chi-Chih WangChi-Chih Wang
Chi-Chih Wang
MTMing-Chang Tsai
Ming-Chang Tsai
CHChao Yen Huang
Chao Yen Huang
CLChun-Che Lin
Chun-Che Lin
MTMing-Hseng Tseng
Ming-Hseng Tseng
Background and Objectives: Barrett’s Esophagus (BE) is a precursor to esophageal adenocarcinoma, and early detection is essential to reduce cancer risk. This study aims to develop a YOLO-based ensemble framework to improve the automated detection of BE-associated mucosal lesions on endoscopic images. Methods: A dataset of 3620 annotated endoscopic images was collected from 132 patients. Five YOLO variants, YOLOv5, YOLOv9, YOLOv10, YOLOv11, and YOLOv12, were selected based on their architectural diversity and detection capabilities. Each model was trained individually, and their outputs were integrated using a Non-Maximum Suppression (NMS)-based ensemble strategy. Multiple ensemble configurations were evaluated to assess the impact of fusion depth on detection performance. Results: The ensemble models consistently outperformed individual YOLO variants in recall, the primary evaluation metric. The entire five-model ensemble achieved the highest recall (0.974), significantly reducing missed lesion detections. Statistical analysis using McNemar’s test and bootstrap confidence intervals confirmed the superiority in most comparisons. Conclusions: The proposed YOLO ensemble framework demonstrates enhanced sensitivity and robustness in detecting BE lesions. Its integration into clinical workflows can improve early diagnosis and reduce diagnostic workload, offering a promising tool for computer-aided screening in gastroenterology.

28 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Chi-Chih WangChi-Chih Wang
Chi-Chih Wang
JHJing-Yang Huang
Jing-Yang Huang
LWLi-Han Weng
Li-Han Weng
YHYao-Chun Hsu
Yao-Chun Hsu
Wen-Wei SungWen-Wei Sung
Wen-Wei Sung
MTMing-Chang Tsai
Ming-Chang Tsai
(1) Background: Previous studies have raised concerns about a potential increase in pancreaticobiliary cancer risk after cholecystectomy, but few studies have focused on patients who undergo cholecystectomy after receiving endoscopic retrograde cholangiopancreatography (ERCP) for choledocholithiasis. This study aims to clarify cancer risks in these patients, who usually require cholecystectomy, to reduce recurrent biliary events. (2) Methods: We conducted a nationwide cohort study linked to the National Health Insurance Research Database, the Cancer Registry Database, and the Death Registry Records to evaluate the risk of pancreaticobiliary cancers. All patients who underwent first-time therapeutic ERCP for choledocholithiasis from 2011 to 2017 in Taiwan were included. We collected the data of 13,413 patients who received cholecystectomy after endoscopic retrograde cholangiopancreatography and used propensity score matching to obtain the data of 13,330 patients in both the cholecystectomy and non-cholecystectomy groups with similar age, gender, and known pancreaticobiliary cancer risk factors. Pancreaticobiliary cancer incidences were further compared. (3) Results: In the cholecystectomy group, 60 patients had cholangiocarcinoma, 61 patients had pancreatic cancer, and 15 patients had ampullary cancer. In the non-cholecystectomy group, 168 cases had cholangiocarcinoma, 101 patients had pancreatic cancer, and 49 patients had ampullary cancer. The incidence rates of cholangiocarcinoma, pancreatic cancer, and ampullary cancer were 1.19, 1.21, and 0.3 per 1000 person-years in the cholecystectomy group, all significantly lower than 3.52 (p < 0.0001), 2.11 (p = 0.0007), and 1.02 (p < 0.0001) per 1000 person-years, respectively, in the non-cholecystectomy group. (4) Conclusions: In patients receiving ERCP for choledocholithiasis, cholecystectomy is associated with a significantly lower risk of developing pancreaticobiliary cancer